US Patent 11779654 PCSK9 endonuclease variants, compositions, and methods of use
Patent 11779654 was granted and assigned to 2seventy bio, Inc. on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+21 properties)
Article (+305 characters)
US Patent 11779654 PCSK9 endonuclease variants, compositions, and methods of use
Article
Patent abstract
The present disclosure provides improved genome editing compositions and methods for editing a PCSK9 gene. The disclosure further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of hypercholesterolemia or a condition associated therewith.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jordan Jarjour
Kyle Havens
Max Echterling
Michael Certo
Date of Patent
October 10, 2023
Patent Application Number
16753117
Date Filed
October 4, 2018
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11779654 PCSK9 endonuclease variants, compositions, and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.